Background
==========

Acute kidney injury (AKI) is a serious complication with high mortality and morbidity rates, and is characterized by sudden loss of kidney function \[[@b1-medscimonit-25-5606]--[@b3-medscimonit-25-5606]\]. Studies have demonstrated the application of specific therapies to alleviate AKI or accelerate rehabilitation \[[@b4-medscimonit-25-5606]--[@b9-medscimonit-25-5606]\], but the prognosis of patients with AKI is still poor due to various and complicated causes \[[@b10-medscimonit-25-5606],[@b11-medscimonit-25-5606]\]. Therefore, it is necessary to establish a risk factor scoring system for AKI to improve the prognosis of patients with AKI.

Acute respiratory distress syndrome (ARDS), a severe form of acute respiratory failure, is characterized by disruption of the endothelial barrier of capillaries lining the alveoli with increased permeability, leading to an intense inflammatory insult, alveolar epithelial injury, and influx of protein-rich edema fluid into the alveoli, causing impaired gas exchange, decreased lung compliance, and increased work of breathing \[[@b12-medscimonit-25-5606]--[@b14-medscimonit-25-5606]\]. Previous studies have reported that the incidence of AKI is up to 35% among ARDS patients in the intensive care unit (ICU), revealing the relationship between patients with acute respiratory failure such as ARDS and the growing mortality rates in patients who developed AKI \[[@b15-medscimonit-25-5606]--[@b17-medscimonit-25-5606]\]. Multicenter studies show that the ARDS mortality rate in China is 68.5% in adult ICUs, and when AKI was complicated by acute lung injury (ALI), the mortality rate is as high as 80% \[[@b18-medscimonit-25-5606]\]. To the best of our knowledge, however, the relationship of different levels of ARDS and AKI in patients with milder diseases have been rarely reported.

In this study we investigated the risk factors associated with development and prognosis of AKI in hospitalized ARDS patients, and established a scoring system based on these risks.

Material and Methods
====================

Patients
--------

A total of 501 patients with ARDS were (296 males and 205 females) admitted to the First People's Hospital of Lianyungang from Aug 2015 to Aug 2017. This study was approved by the Institutional Review Board of the First People's Hospital of Lianyungang (approval number LW20190125001).

Inclusion and exclusion criteria
--------------------------------

Patients who met the following criteria were included: (1) met Berlin diagnostic criteria for ARDS, (2) at least 18 years old, and (3) admission to the respiratory intensive care unit or general ward.

Excluded criteria were: (1) tumors, (2) chronic kidney disease (CKD) stage 5 or undergoing renal replacement therapy (peritoneal dialysis or hemodialysis) before hospitalization, (3) incomplete clinical data and unclear basal serum creatinine, and (4) admission time ≤48 h.

Diagnosis criteria
------------------

The following Berlin diagnostic criteria for ARDS \[[@b13-medscimonit-25-5606]\] were used: (1) the new or pejorative respiratory symptoms with clear clinical symptoms or injuries within 1 week, (2) infiltrates in both lungs cannot be completely exuded through the lungs, lung collapse, or pulmonary nodules, (3) respiratory failure cannot be fully explained via heart failure or excessive volume load, and (4) oxygenation index classified as (a) mild: 200 mmHg \<PaO~2~/FiO~2~ ≤300 mmHg, and PEEP or CAPA ≥5 cmH~2~O; (b) moderate: 100 mmHg \<PaO~2~/FiO~2~ ≤200 mmHg, and PEEP ≥5 cmH~2~O; and (c) severe: PaO~2~/FiO~2~ ≤100 mmHg, and PEEP ≥5 cmH~2~O.

Diagnostic criteria for patients with AKI conformed to the revised AKI diagnosis criteria of the 2012 Kidney Disease Improving Global Outcomes (KDIGO) \[[@b19-medscimonit-25-5606]\], in which presence of any 1 of the following characteristics can lead to diagnosis of AKI: (a) suddenly decline in renal function within 48 h, (b) an increasing absolute value in serum creatinine not less than 0.3 mg/dL (≥26.4 mmol/L), (c) blood creatinine at least 50% above than the baseline value, and (d) decreased urine output (urinary volume \<0.5 mL/kg^.^h) for more than 6 h. The base creatinine concentration was the 3-month creatinine level before admission or minimum creatinine after admission.

Clinical risk scoring system
----------------------------

Logistic regression analysis was used to establish a clinical risk scoring for AKI, which was refined by Takagi et al. \[[@b20-medscimonit-25-5606]\]. The multivariable logistic model was constructed to select significant variables which were assigned scores proportional to the adjusted OR. The variables with no statistical significance were explicitly defined as 1 point. The predictors with statistical significance were assigned an integer fraction which was proportional to OR. Then, the sum of weighted variables was used to estimate a patient's score. The 4 risk categories were determined based on quartile of total score: group A (score 0--2), group B (score 3--4), group C (score 5--6), and group D (score ≥7).

Statistical analysis
--------------------

Statistical analysis was performed using SPSS 24.0 (SPSS, Inc., Chicago, IL). Count data were presented as n (%) with chi-square test or logistic regression. The risk factors were screened by multivariable logistic regression analysis. *P*\<0.05 were considered to be a statistically significant difference.

Results
=======

Study population
----------------

As shown in [Table 1](#t1-medscimonit-25-5606){ref-type="table"}, the parameters of sex, age, smoke, respiratory failure type, blood glucose, pulmonary arterial (PA), and encephalopathy were no significantly different between the 2 groups (*P*\>0.05).

Factors analysis of AKI
-----------------------

The single and multiple factors analyses of AKI are presented in [Tables 2](#t2-medscimonit-25-5606){ref-type="table"} and [3](#t3-medscimonit-25-5606){ref-type="table"}, respectively. There were statistically obvious differences between the N-AKI and AKI groups in diabetics, consciousness, hypertension, ARDS, AF, pleural effusion, heart disease, aspartate aminotransferase (AST), and D-dimer ([Table 2](#t2-medscimonit-25-5606){ref-type="table"}) (*P*\<0.05). Patients with ARDS who had unconsciousness (OR=2.778, 95% CI: 1.396--5.528), hypertension (OR=1.771, 95% CI: 1.089--2.881), ARDS (moderate--severe) (OR=1.630, 95% CI: 1.027--2.588), AST (OR=2.093, 95% CI: 1.251--3.499), or D-dimer (OR=2.372, 95% CI: 1.316--4.275) were more likely to also have AKI ([Table 3](#t3-medscimonit-25-5606){ref-type="table"}).

Model scoring
-------------

The assigned score of the correlative predictors are displayed in [Table 3](#t3-medscimonit-25-5606){ref-type="table"}. Five significant predictors selected from the multivariable logistic model were assigned integer scores proportional to the OR. The variables with no significant differences (bronchial disease, diabetes, AF, pleural effusion, and heart disease) were assigned 1 point. Ultimately, these 12 predictors were integrated into the risk scoring system.

The distribution of the points and correlated prevalence of AKI is shown in [Figure 1](#f1-medscimonit-25-5606){ref-type="fig"}. The incidences of AKI were 10.71% (score 0), 10.53% (score 1), 11.43% (score 2), 10.71% (score 3), 22.73% (score 4), 35.42% (score 5), 27.59% (score 6), 37.50% (score 7), and 54.29% (score ≥8).

Correlation analysis of different scoring groups
------------------------------------------------

The prevalence of AKI was s significantly different in the different scoring groups (χ^2^=50.183, *P*\<0.001). Higher scores were associated with higher prevalence of AKI (*P~trend~* \<0.001) ([Table 4](#t4-medscimonit-25-5606){ref-type="table"}).

In this study, 4 risk categories were determined based on the scoring points: group A (score 0--2, n=9), group B (score 3--4, n=16), group C (score 5--6, n=33), and group D (score ≥7, n=72). As shown in [Figure 2](#f2-medscimonit-25-5606){ref-type="fig"}, the incidences of AKI in groups A, B, C, and D were 10.98%, 16.00%, 31.13%, and 49.66%, respectively (*P*\<0.001).

The results of correlation analysis between the 3 risk groups and prognosis showed that less improvement was significantly associated with higher risk (χ^2^=23.057, *P*\<0.001) ([Table 5](#t5-medscimonit-25-5606){ref-type="table"}, [Figure 3](#f3-medscimonit-25-5606){ref-type="fig"}).

Discussion
==========

The present study established a risk scoring system for patients with ARDS who developed AKI. Our results determined that this AKI risk score, in which 5 predictive factors based on the multiple-factor logistic regression were analyzed, displayed an obvious correlation with the development and prognosis of AKI. According to the score, 4 risk levels were defined and used to develop explicit risk stratification of AKI, and risk prediction was performed using the risk scoring system in the internal validation. To the best of our knowledge, it is the first published clinical risk scoring system for AKI patients.

Ashbaugh et al. first performed risk scoring for ARDS in 1967 \[[@b21-medscimonit-25-5606]\], which is characterized by diffuse lesions of pulmonary endothelial and alveolar epithelium cells, resulting in alveolar and interstitial tissue flooding and edema, reduced lung compliance, imbalanced lung ventilation flow ratio, decreased lung volume, and refractory dyspnea \[[@b22-medscimonit-25-5606]--[@b24-medscimonit-25-5606]\]. The literature shows that AKI can lead to the release of various inflammatory factors and cytokines *in vivo* and promote the expression of pro-inflammatory genes in healthy lungs \[[@b25-medscimonit-25-5606]\]. AKI is an important cause of mortality and morbidity in critically ill patients in ICUs \[[@b26-medscimonit-25-5606]\]. A study demonstrated that IL-6, soluble TNF receptors, and plasminogen activator inhibitor-1 are associated independently with AKI during mechanical ventilation \[[@b27-medscimonit-25-5606]\]. Use of positive-pressure ventilation was reported to be associated with activation of the renin-angiotensin system, the sympathetic nervous system, and hemodynamic changes, which may reduce renal blood flow (RBF), glomerular filtration rate (GFR), and free water clearance \[[@b17-medscimonit-25-5606]\]. It was reported that hypoxemia can affect renal vascular resistance and increase diuresis \[[@b17-medscimonit-25-5606],[@b28-medscimonit-25-5606]\]. An experimental model of ARDS verified that renal end-organ injury can be induced through the high-volume ventilation \[[@b29-medscimonit-25-5606],[@b30-medscimonit-25-5606]\]. Previous data analyses of ARDS co-occurring with AKI was mostly from ICU cases who had serious illness, many complications, and multiple-organ damage \[[@b17-medscimonit-25-5606],[@b31-medscimonit-25-5606]\], and the survival rate was obviously decreased. In the present study, therefore, we developed and assessed a risk scoring system to predict development of AKI and prognosis for patients with ARDS.

In this work, a risk scoring system for AKI, which included multiple risk factors and assessed adverse events, was developed in AKI patients. The relevant clinical data required for this scoring system can be easily obtained, which would helpful predict prognosis of AKI patients. Furthermore, the prognostic stratification may inform individualized management involving assessment of the need for intensive medical therapy and close follow-up. Thus, it is of clinical significance to improve the compliance of high-risk patients by enhancing awareness using the risk scoring system.

A limitation of the present study is that the scoring system is only appropriate for AKI patients, and whether it would be applicable for other patients needs further study. The scoring system was developed and assessed at 2 hospitals, and whether it is applicable in other settings is unknown. As with all retrospective studies, there may have been some incompletely collected data and some missing values, and there was only 1 indicator of liver function. Thus, multicenter studies with larger samples and including multiple diseases and hemodynamic indicators are needed for further verification of this scoring system in clinical practice.

Conclusions
===========

We analyzed risk factors in the development and prognosis of AKI in patients with ARDS, and developed a clinical risk prediction scoring system for AKI patients. The scoring system may provide risk-integrative evaluation and prognostic stratification for AKI patients.
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###### 

Comparison for sociological characteristics between the 2 groups.

  Variable              Classification   Group n (%)   χ^2^          *P*     
  --------------------- ---------------- ------------- ------------- ------- -------
  Sex                   Male             203 (57.51)   93 (62.84)    1.226   0.268
  Female                150 (42.49)      55 (37.16)                          
  Age                   \<60             50 (14.16)    19 (12.84)    1.233   0.540
  60--75                148 (41.93)      56 (37.84)                          
  \>75                  155 (43.91)      73 (49.32)                          
  Smoke                 No               237 (67.14)   110 (74.32)   2.529   0.112
  Yes                   116 (32.86)      38 (26.03)                          
  Respiratory failure   I                179 (50.71)   76 (51.35)    0.053   0.974
  II                    171 (48.44)      71 (47.97)                          
  Normal                3 (0.85)         1 (0.68)                            
  Blood glucose         Anomaly          202 (57.22)   95 (64.19)    2.096   0.148
  Normal                151 (42.78)      53 (35.81)                          
  PA                    Normal           237 (69.10)   105 (70.95)   1.157   0.740
  Mild                  54 (15.74)       20 (13.51)                          
  Moderate              33 (9.62)        12 (8.11)                           
  Severe                19 (5.54)        11 (7.43)                           
  Encephalopathy        No               277 (78.47)   105 (70.95)   3.260   0.071
  Yes                   76 (21.53)       43 (29.05)                          

N-AKI -- non-acute kidney injury; AKI -- acute kidney injury; PA -- pulmonary arterial.

###### 

Single-factor analysis of AKI.

  Variable            Classification   Group n (%)   OR            95% CI         *P*       
  ------------------- ---------------- ------------- ------------- -------------- --------- --
  Diagnosis           COPD             188 (53.26)   60 (40.54)    1              --        
  Bronchial disease   47 (13.31)       11 (7.43)     0.733         0.358--1.503   0.397     
  Pneumonia           100 (28.33)      68 (45.95)    2.131         1.395--3.254   0.001     
  Others              18 (5.10)        9 (6.08)      1.567         0.669--3.670   0.301     
  Diabetes            No               309 (88.03)   115 (77.70)   1              --        
  Yes                 42 (11.97)       33 (22.30)    2.112         1.276--3.494   0.003     
  Miss                2                0             --            --                       
  Consciousness       No               23 (6.52)     31 (20.95)    1              --        
  Yes                 330 (93.48)      117 (79.05)   0.263         0.147--0.469   \<0.001   
  Hypertension        No               239 (76.36)   74 (23.64)    1              --        
  Yes                 114 (60.64)      74 (39.36)    2.097         1.417--3.102   \<0.001   
  ARDS                Mild             202 (57.22)   57 (38.51)    1              --        
  Moderate--severe    151 (42.78)      91 (61.49)    2.121         1.420--3.170   \<0.001   
  AF                  No               327 (92.63)   122 (82.43)   1              --        
  Yes                 26 (7.37)        26 (17.57)    2.680         1.497--4.796   0.001     
  Pleural effusion    No               259 (73.37)   89 (60.14)    1              --        
  Yes                 94 (26.63)       59 (39.86)    1.827         1.218--2.739   0.003     
  Heart disease       No               215 (66.56)   72 (53.33)    1              --        
  Yes                 108 (33.44)      63 (46.67)    1.742         1.157--2.624   0.008     
  Miss                30               13            --            --                       
  AST                 Normal           292 (82.72)   92 (62.16)    1              --        
  Abnormal            61 (17.28)       56 (37.84)    2.914         1.892--4.487   \<0.001   
  D-dimer             Normal           137 (40.90)   23 (16.08)    1              --        
  Abnormal            198 (59.10)      120 (83.92)   3.610         2.197--5.931   \<0.001   
  Miss                18               5             --            --                       

N-AKI -- non-acute kidney injury; AKI -- acute kidney injury; COPD -- chronic obstructive pulmonary disease; ARDS -- acute respiratory distress syndrome; AF -- atrial fibrillation; AST -- aspartate aminotransferase.

###### 

Multivariable logistic analysis of AKI.

  Variable                        β        S.E.    Wald     *P*       OR      95% CI   Assigned score   
  ------------------------------- -------- ------- -------- --------- ------- -------- ---------------- ----
  Constant                        −2.578   0.311   68.908   \<0.001   --      --       --               --
  Diagnosis (bronchial disease)   −0.100   0.421   0.057    0.812     0.905   0.397    2.063            1
  Diagnosis (pneumonia)           0.156    0.266   0.342    0.558     1.168   0.694    1.968            1
  Diagnosis (others)              0.156    0.521   0.089    0.765     1.168   0.421    3.244            1
  Diabetes (yes)                  0.359    0.314   1.301    0.254     1.431   0.773    2.651            1
  Consciousness (no)              1.022    0.351   8.464    0.004     2.778   1.396    5.528            3
  Hypertension (yes)              0.572    0.248   5.299    0.021     1.771   1.089    2.881            2
  ARDS (moderate--severe)         0.489    0.236   4.292    0.038     1.630   1.027    2.588            2
  AF (yes)                        0.469    0.356   1.733    0.188     1.598   0.795    3.211            1
  Pleural effusion (yes)          0.089    0.253   0.124    0.725     1.093   0.666    1.793            1
  Heart disease (yes)             0.213    0.251   0.721    0.396     1.237   0.757    2.022            1
  AST (abnormal)                  0.738    0.262   7.925    0.005     2.093   1.251    3.499            2
  D-dimer (abnormal)              0.864    0.301   8.258    0.004     2.372   1.316    4.275            2

ARDS -- acute respiratory distress syndrome; AF -- atrial fibrillation; AST -- aspartate aminotransferase.

###### 

The relationship between the 4 risk groups and the prevalence of AKI.

  Group   Group        χ^2^         *P*      *P~trend~*   
  ------- ------------ ------------ -------- ------------ ---------
  A       73 (89.02)   9 (10.98)    50.183   \<0.001      \<0.001
  B       84 (84.00)   16 (16.00)                         
  C       73 (68.87)   33 (31.13)                         
  D       73 (50.34)   72 (49.66)                         

443 cases were included in this scoring system based on the logistic regression analysis. N-AKI -- non-acute kidney injury; AKI -- acute kidney injury. A -- score 0--2; B -- score 3--4; C -- score 5--6; D: score ≥7.

###### 

Correlation analysis of the 4 risk groups and prognosis.

  Group   Prognosis n (%)   χ^2^         *P*                   
  ------- ----------------- ------------ ------------ -------- ---------
  A       74 (90.24)        8 (9.76)     0 (0.00)     23.057   \<0.001
  B       82 (82.00)        10 (10.00)   8 (8.00)              
  C       83 (78.30)        7 (6.60)     16 (15.09)            
  D       95 (65.22)        18 (12.41)   32 (22.07)            

443 cases were included in this scoring system based on the logistic regression analysis. A -- score 0--2; B -- score 3--4; C -- score 5--6; D -- score ≥7.
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